You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PD-1 inhibition

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Cell Carcinoma of the Head and Neck Trial in Stanford ([18F]F-AraG PET Scan, baseline + post anti-PD-1 therapy.)

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • [18F]F-AraG PET Scan, baseline + post anti-PD-1 therapy.
  • Stanford, California
    Stanford Hospital and Clinics
Dec 1, 2022

Breast Cancer Trial in Ottawa, Toronto (Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab)

Not yet recruiting
  • Breast Cancer
  • Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab
  • Ottawa, Ontario, Canada
  • +1 more
Jul 22, 2023

Advanced Solid Tumor, Lymphoma Trial in United States (ALPN-202, Pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumor
  • Lymphoma
  • Atlanta, Georgia
  • +4 more
Nov 8, 2022

Glioma, IDH Mutation, Astrocytoma Trial in Philadelphia (Retifanlimab, All-trans retinoic acid)

Not yet recruiting
  • Glioma
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 22, 2022

Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Miami, Florida
    University of Miami
Jun 27, 2022

Metastatic Colorectal Cancer, MSS Trial in Heidelberg (Pembrolizumab, Maraviroc)

Completed
Has Results
  • Metastatic Colorectal Cancer
  • MSS
  • Heidelberg, Germany
    National Center for Tumor Diseases, University Hospital Heidelbe
May 17, 2022

Metastatic Malignant Tumor in the Bone, Stage IV Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Bone
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 4, 2023

Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck Trial in La Jolla (Ibrutinib 560mg PO daily (Imbruvica),

Active, not recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma of the Head and Neck
  • Ibrutinib 560mg PO daily (Imbruvica)
  • +2 more
  • La Jolla, California
    UCSD Moores Cancer Center
Jan 11, 2023

HNSCC Trial in Cincinnati, Cleveland, Philadelphia (Cesium-131, Pembrolizumab)

Recruiting
  • HNSCC
  • Cincinnati, Ohio
  • +2 more
Oct 4, 2022

Metastatic Soft-tissue Sarcoma Trial in United States (Cabozantinib, Nivolumab, Ipilimumab)

Recruiting
  • Metastatic Soft-tissue Sarcoma
  • Stanford, California
  • +3 more
Jan 10, 2023

Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8 Trial

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +6 more
  • Durvalumab
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Mar 29, 2022

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • KEYTRUDA®
  • (no location specified)
Nov 17, 2023

Cutaneous Metastases Trial in New York (Diphencyprone (DPCP))

Not yet recruiting
  • Cutaneous Metastases
  • Diphencyprone (DPCP)
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 28, 2022

Head and Neck Squamous Cell Carcinoma Trial (TTI-101, Pembrolizumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Dec 20, 2022

Chronic Phase Myelofibrosis, Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Boston, Bronx, New

Completed
Has Results
  • Chronic Phase Myelofibrosis
  • +3 more
  • Boston, Massachusetts
  • +2 more
May 27, 2021

Endometrial Cancer, Cancer of the Endometrium Trial in Saint Louis (drug, radiation, procedure)

Recruiting
  • Endometrial Cancer
  • Cancer of the Endometrium
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 4, 2022

Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and

Recruiting
  • Leptomeningeal Metastasis
  • +2 more
  • intrathecal nivolumab and intrathecal ipilimumab
  • Geneva, Switzerland
  • +2 more
Dec 18, 2022

Invasive Breast Cancer Trial in Milwaukee (Cemiplimab, Paclitaxel, Carboplatin (not mandatory))

Recruiting
  • Invasive Breast Cancer
  • Milwaukee, Wisconsin
    Froedtert Hospital & Medical College of Wisconsin
Apr 1, 2022

Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell

Not yet recruiting
  • Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +2 more
  • Biopsy
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 28, 2023

Malignant Pleural Mesothelioma Trial in Philadelphia (OT-101)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jun 16, 2022

Colorectal Cancer Metastatic Trial in Australia (Nivolumab 10 MG/ML, BNC 105, BBI608)

Completed
  • Colorectal Cancer Metastatic
  • Nivolumab 10 MG/ML
  • +2 more
  • Albury, New South Wales, Australia
  • +13 more
Aug 26, 2021

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Blasts Under

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +3 more
  • Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 10, 2022

Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Chapel Hill (Nivolumab, Pembrolizumab)

Recruiting
  • Relapsed Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Nivolumab
  • Pembrolizumab
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Jul 22, 2022

Glioblastoma Trial in Philadelphia (CART-EGFRvIII T cells, Pembrolizumab)

Completed
  • Glioblastoma
  • CART-EGFRvIII T cells
  • Pembrolizumab
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 2, 2021

Urothelial Carcinoma Recurrent, Advanced Urothelial Carcinoma Trial in San Francisco, Buffalo (Vactosertib(TEW-7197)/

Not yet recruiting
  • Urothelial Carcinoma Recurrent
  • Advanced Urothelial Carcinoma
  • Vactosertib(TEW-7197)/ Durvalumab
  • San Francisco, California
  • +1 more
Sep 22, 2021